Ardelyx Inc (ARDX)
5.85
-0.04
(-0.68%)
USD |
NASDAQ |
Nov 05, 09:31
Ardelyx Price: 5.85 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 5.96 | 6.05 | 5.76 | 5.89 | 4.065M |
| Nov 01, 2024 | 5.99 | 6.44 | 5.88 | 6.09 | 8.138M |
| Oct 31, 2024 | 5.90 | 6.005 | 5.80 | 5.87 | 6.099M |
| Oct 30, 2024 | 6.00 | 6.05 | 5.87 | 5.89 | 2.422M |
| Oct 29, 2024 | 5.88 | 6.02 | 5.80 | 6.01 | 1.902M |
| Oct 28, 2024 | 5.82 | 6.00 | 5.80 | 5.90 | 2.286M |
| Oct 25, 2024 | 5.88 | 5.93 | 5.76 | 5.77 | 1.586M |
| Oct 24, 2024 | 5.65 | 5.92 | 5.60 | 5.86 | 3.068M |
| Oct 23, 2024 | 5.76 | 5.785 | 5.55 | 5.58 | 2.989M |
| Oct 22, 2024 | 5.83 | 5.89 | 5.65 | 5.78 | 2.317M |
| Oct 21, 2024 | 5.80 | 5.89 | 5.73 | 5.88 | 3.547M |
| Oct 18, 2024 | 5.84 | 5.96 | 5.81 | 5.84 | 1.975M |
| Oct 17, 2024 | 5.90 | 5.92 | 5.62 | 5.83 | 3.647M |
| Oct 16, 2024 | 5.98 | 6.015 | 5.78 | 5.85 | 2.644M |
| Oct 15, 2024 | 6.03 | 6.06 | 5.935 | 5.97 | 2.033M |
| Oct 14, 2024 | 6.00 | 6.08 | 5.925 | 5.99 | 2.225M |
| Oct 11, 2024 | 6.01 | 6.10 | 5.86 | 6.04 | 3.008M |
| Oct 10, 2024 | 5.85 | 6.07 | 5.77 | 6.04 | 2.156M |
| Oct 09, 2024 | 5.98 | 6.03 | 5.84 | 5.87 | 4.062M |
| Oct 08, 2024 | 6.15 | 6.19 | 5.95 | 5.96 | 3.017M |
| Oct 07, 2024 | 6.81 | 6.84 | 6.09 | 6.13 | 5.933M |
| Oct 04, 2024 | 6.71 | 6.88 | 6.71 | 6.82 | 1.815M |
| Oct 03, 2024 | 6.83 | 6.90 | 6.65 | 6.66 | 2.645M |
| Oct 02, 2024 | 6.85 | 7.04 | 6.695 | 6.93 | 3.795M |
| Oct 01, 2024 | 6.85 | 6.87 | 6.515 | 6.85 | 4.161M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.5101
Minimum
Jun 14 2022
9.74
Maximum
Feb 09 2024
4.595
Average
5.33
Median
Mar 20 2020
Price Benchmarks
| Verve Therapeutics Inc | 6.33 |
| United Therapeutics Corp | 375.52 |
| NovaBay Pharmaceuticals Inc | 0.731 |
| Palatin Technologies Inc | 1.19 |
| iBio Inc | 2.67 |
Price Related Metrics
| PS Ratio | 5.435 |
| PEG Ratio | -0.1158 |
| Price to Book Value | 8.753 |
| Earnings Yield | -5.36% |
| Market Cap | 1.386B |
| PEGY Ratio | -0.1158 |